Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127033441 | 12703344 | 1 | I | 20160727 | 20160822 | 20160831 | 20160831 | EXP | GB-MHRA-EYC 00143908 | GB-SA-2016SA154959 | AVENTIS | 79.00 | YR | E | F | Y | 60.00000 | KG | 20160831 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127033441 | 12703344 | 1 | PS | INDAPAMIDE. | INDAPAMIDE | 1 | Oral | Y | UNK | 18538 | 2.5 | MG | |||||||
| 127033441 | 12703344 | 2 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127033441 | 12703344 | 1 | Essential hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127033441 | 12703344 | HO |
| 127033441 | 12703344 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127033441 | 12703344 | Asthenia | |
| 127033441 | 12703344 | Confusional state | |
| 127033441 | 12703344 | Fatigue | |
| 127033441 | 12703344 | Hyponatraemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127033441 | 12703344 | 1 | 20160727 | 20160803 | 0 |